The management of functional mitral regurgitation

Current Cardiology Reports

Volumn 9, Issue 2, 2007, Pages 112-117

  Carabello, Blase Anthony ^a  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ANNULOPLASTY; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; DISEASE CLASSIFICATION; DISEASE SEVERITY; EXERCISE TOLERANCE; HEALING; HEART AFTERLOAD; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE OVERLOAD; HEART LEFT VENTRICLE VOLUME; HEART LEFT VENTRICLE WALL MOTION; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART PAPILLARY MUSCLE; HEART VALVE SURGERY; HEART VENTRICLE REMODELING; HUMAN; MITRAL VALVE DISEASE; MITRAL VALVE REGURGITATION; MORTALITY; NEUROENDOCRINE SYSTEM; NONHUMAN; OUTCOMES RESEARCH; PROGNOSIS; REVIEW; RHEUMATIC HEART DISEASE;

HEART FAILURE, CONGESTIVE; HUMANS; MITRAL VALVE INSUFFICIENCY; MYOCARDIAL CONTRACTION; PROGNOSIS; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 34247560145     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02938337     Document Type: Review

References (41)

1. Nakano K, Swindle MM, Spinale F, et al.: Depressed contractile function due to canine mitral regurgitation improves after correction of the volume overload. J Clin Invest 1991, 87:2077-2086.
2. Starling MR: Effects of valve surgery on left ventricular contractile function in patients with long-term mitral regurgitation. Circulation 1995, 92:811-818.
3. Enriquez-Sarano M, Tajik AJ, Schaff HV, et al.: Echocardiographic prediction of survival after surgical correction of organic mitral regurgitation. Circulation 1994, 90:830-837.
4. Enriguez-Sarano M, Schaff HV, Orszulak TA, et al.: Valve repair improves the outcome of surgery for mitral regurgitation. A multivariate analysis. Circulation 1995, 91:1264-1265.
5. Horstkotte D, Schulte HD, Bircks W, et al.: The effect of chordal preservation on late outcome after mitral valve replacement: a randomized study. J Heart Valve Dis 1993, 2:150-158.
6. Kuwahara E, Otsuji Y, Iguro Y, et al.: Mechanisms of recurrent/ persistent ischemic/functional mitral regurgitation in the chronic phase after surgical annuloplasty: importance of augmented posterior leaflet tethering. Circulation 2006, 114(1 Suppi):I529-I534.
7. Kwan J, Shiota T, Agler DA, et al.: Real-time three-dimensional echocardiography study. Geometric differences of the mitral apparatus between ischemic and dilated cardiomyopathy with significant mitral regurgitation: real-time three-dimensional echocardiography study. Circulation 2003, 107:1135-1140.
8. Lamas GS, Mitchell GF, Flaker GC, et al.: Clinical significance of mitral regurgitation after acute myocardial infarction. Survival and Ventricular Enlargement Investigators. Circulation 1997, 96:827-833.
9. Tcheng JE, Jackman JD, Nelson CL, et al.: Outcome of patients sustaining acute ischemic mitral regurgitation during myocardial infarction. Ann Intern Med 1992, 117:18-24.
10. Trichon BH, Felker GM, Shaw LK, et al.: Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. Am J Cardiol 2003, 91:538-543.
11. Carabello BA, Williams H, Gash AK, et al.: Hemodynamic predictors of outcome in patients undergoing valve replacement. Circulation 1986, 74:1309-1316.
12. Carabello BA, Kann C, De Leon AC Jr, et al.: ACC/AHA 2006 guidelines for management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and interventions and the Society of Thoracic Surgeons. Circulation 2006, 114:e84-e231.
13. Thackray S, Witte K, Clark A, et al.: Clinical trials update: OPTIME-CHF, PRAISE-2, ALL-HAT. Eur J Heart Fail 2000, 2:209-212.
14. Cohn J, Ziesche S, Smith R, et al.: Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-HeFT III. Vasodilator-Heart Failure Trial (V-HeFT) Study Group. Circulation 1997, 96:856-863.
15. Horstkotte D, Schulte HD, Niehus R, et al.: Diagnostic and therapeutic considerations in acute, severe mitral regurgitation: Experience in 42 consecutive patients entering the intensive care unit with pulmonary edema. J Heart Valve Dis 1993, 2:512-522.
16. Wisenbaugh T, Sinovich V, Dullabh A, et al.: Six month pilot study of captopril for mildly symptomatic, severe isolated mitral and isolated aortic regurgitation. J Heart Valve Dis 1994, 3:197-204.
17. Marcotte F, Honos GN, Walling AD, et al.: Effect of angiotensin-converting enzyme inhibitor therapy in mitral regurgitation with normal left ventricular function. Can J Cardiol 1997, 13:479-485.
18. Cleland JG, Daubert JC, Erdmann E, et al.: Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. N Engl J Med 2005, 352:1539-1549.
19. Bradley DJ, Bradley EA, Baughman KL, et al.: Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials. JAMA 2003, 289:730-740.
20. St. John Sutton MG, Plappert T, Abraham WT, et al.: Multicenter InSync Randomized Clinical Evaluation (MIRACLE) Study Group. Circulation 2003, 107:1985-1990.
21. Trichon BH, Glower DD, Shaw LK, et al.: Survival after coronary revascularization, with and without mitral valve surgery, in patients with ischemic mitral regurgitation. Circulation, 108(Suppl 1):II103-II110.
22. Harris KM, Sundt TM 3rd, Aeppli D, et al.: Can late survival of patients with moderate ischemic mitral regurgitation be impacted by intervention on the valve? Ann Thorac Surg 2002, 74:1468-1475.
23. Pinson CW, Cobanoglu A, Metzdorff MT, et al.: Late surgical results for ischemic mitral regurgitation. Role of wall motion score and severity of regurgitation. J Thorac Cardiovasc Surg 1984, 88(5 Pt 1):663-672.
24. Grossi EA, Goldberg JD, LaPietra A, et al.: Ischemic mitral valve reconstruction and replacement: comparison of long-term survival and complication. J Thorac Cardiovasc Surg 2001, 122:1107-1124.
25. Kim YH, Czer LS, Soukiasian HJ, et al.: Ischemic mitral regurgitation. revascularization alone versus revascularization and mitral valve paper. Ann Thorac Surg 2005, 79:1895-1901.
26. Prifti E, Bonacchi M, Frati G, et al.: Ischemic mitral valve regurgitation grade II-III: correction in patients with impaired left ventricular function undergoing simultaneous coronary revascularization. J Heart Valve Dis 2001, 10:754-762.
27. Gillinov AM, Faber C, Houghtaling PL, et al.: Repair versus replacement for degenerative mitral valve disease with coexisting ischemic heart disease. J Thorac Cardiovasc Surg 2003, 125:1350-1362.
28. Cohn LH, Rizzo RJ, Adams DH, et al.: The effect of pathophysiology on the surgical treatment of ischemic mitral regurgitation: operative and late risks of repair versus replacement. Eur J Cardiothrac Surg 1995, 9:568-574.
29. Gillinov AM: Is ischemic mitral regurgitation an indication for surgical repair or replacement? Heart Fail Rev 2006, 11:231-239.
30. Schuler G, Peterson KL, Johnson A, et al.: Temporal response of left ventricular performance to mitral valve surgery. Circulation 1979, 59:1218-1231.
31. Boucher CA, Bingham JB, Osbakken MD, et al.: Early changes in left ventricular size and function after correction of left ventricular volume overload. Am J Cardiol 1981, 47:991-1004.
32. David TE, Burns RJ, Baachus CM, et al.: Mitral valve replacement for mitral regurgitation with and without preservation of chordae tendineae. J Thorac Cardiovasc Surg 1984, 88(5 Pt 1):718-725.
33. David TE, Uden DE, Strauss HD: The importance of the mitral apparatus in left ventricular function after correction of mitral regurgitation. Circulation 1983, 68(3 Pt 2): II76-II82.
34. Rozich JD, Carabello BA, Usher BW, et al.: Mitral valve replacement with and without chordal preservation in patients with chronic mitral regurgitation: mechanism for differences in postoperative ejection performance. Circulation 1992, 86:1718-1727.
35. Hansen DE, Sarris GE, Niczyporuk MA, et al.: Physiologic role of the mitral apparatus in left ventricular regional mechanics, contraction synergy, and global systolic performance. J Thorac Cardiovasc Surg 1989, 97:521-533.
36. Sarris GE, Cahill PD, Hansen DE, et al.: Restoration of left ventricular systolic performance after reattachment of the mitral chordae tendineae: the importance of valvular-ventricular interaction. J Thorac Cardiovasc Surg 1988, 95:969-979.
37. Bach DS, Bolling SF: Improvement of following correction of secondary mitral regurgitation in end-stage cardiomyopathy with mitral annuloplasty. Am J Cardiol 1996, 78:966-969.
38. Guy TS IV, Moainie SL, Gorman JH III, et al.: Prevention of ischemic mitral regurgitation does not influence the outcome of remodeling after posterolateral myocardial infarction. J Am Coll Cardiol 2004, 43:377-383.
39. Wu AH, Aaronson KD, Bolling SF, et al.: Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol 2005, 45:381-387.
40. Acker MA, Bolling S, Shemin R, et al.: Acorn Trial Principal Investigators and Study Coordinators. J Thorac Cardiovasc Surg 2006, 132:455-456.
41. Feldman T: Proceedings of TCT: current status of catheter-based mitral valve repair therapies. J Interv Cardiol 2006, 19:396-400.